Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ECE1 | P42892 | 5/20 | 0.60 |
| ▸ | ERAP2 | Q6P179 | 4/20 | 0.60 |
| ▸ | CCKAR | P32238 | 1/20 | 0.59 |
| ▸ | CCKBR | P32239 | 1/20 | 0.59 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.59 |
| ▸ | IL1RN | P18510 | 1/20 | 0.59 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.58 |
| ▸ | ANPEP | P15144 | 1/20 | 0.58 |
| ▸ | NPY1R | P25929 | 3/20 | 0.57 |
| ▸ | NPY2R | P49146 | 3/20 | 0.57 |
| ▸ | NPY4R | P50391 | 3/20 | 0.57 |
| ▸ | GHSR | Q92847 | 1/20 | 0.57 |
| ▸ | ACE | P12821 | 1/20 | 0.56 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.56 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29519671 | 0.96 | ECE1 (0.65) | ECE1ERAP2CCKARCCKBROPRD1 | |
| SCHEMBL30050840 | 0.93 | ECE1 (0.68) | ECE1ERAP2IL1RNERAP1ANPEP | |
| SCHEMBL29381352 | 0.93 | ECE1 (0.68) | ECE1ERAP2IL1RNERAP1ANPEP | |
| SCHEMBL29519590 | 0.89 | ERAP2 (0.55) | ECE1ERAP2IL1RNERAP1ANPEP | |
| SCHEMBL30051190 | 0.89 | ECE1 (0.74) | ECE1ERAP2IL1RNERAP1ANPEP | |
| SCHEMBL30044908 | 0.89 | KISS1R (0.61) | ERAP2IL1RNKISS1R | |
| SCHEMBL30123045 | 0.88 | ECE1 (0.62) | ECE1ERAP2IL1RNERAP1ANPEP | |
| SCHEMBL30845362 | 0.88 | ERAP2 (0.71) | ECE1ERAP2OPRD1IL1RNERAP1 | |
| SCHEMBL30368556 | 0.88 | ACE (0.64) | ECE1ERAP2ERAP1GHSRACE | |
| SCHEMBL14940856 | 0.87 | ECE1 (0.77) | ECE1ERAP2ERAP1ANPEPACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4211146-B1 | SYNTHETIC CYCLIC PEPTIDE MIMETICS | UNIV BAR ILAN (IL) | 2026-05-20 | — | — | EP | claimed |
| US-12616760-B2 | Synthetic cyclic peptide mimetics | BAR ILAN UNIVERSITY (IL) | 2026-05-05 | — | — | US | claimed |
| US-20240316225-A1 | SYNTHETIC CYCLIC PEPTIDE MIMETICS | BAR ILAN UNIVERSITY (IL) | 2024-09-26 | — | — | US | claimed |
| EP-4211146-A1 | SYNTHETIC CYCLIC PEPTIDE MIMETICS | Bar Ilan University (IL) | 2023-07-19 | — | — | EP | claimed |
| WO-2022054062-A1 | SYNTHETIC CYCLIC PEPTIDE MIMETICS | BAR ILAN UNIVERSITY (IL) | 2022-03-17 | — | — | WO | claimed |
| US-12616760-B2 | Synthetic cyclic peptide mimetics | BAR ILAN UNIVERSITY (IL) | 2026-05-05 | — | — | US | disclosed |
| US-20240316225-A1 | SYNTHETIC CYCLIC PEPTIDE MIMETICS | BAR ILAN UNIVERSITY (IL) | 2024-09-26 | — | — | US | disclosed |
| EP-4211146-A1 | SYNTHETIC CYCLIC PEPTIDE MIMETICS | Bar Ilan University (IL) | 2023-07-19 | — | — | EP | disclosed |
| WO-2022054062-A1 | SYNTHETIC CYCLIC PEPTIDE MIMETICS | BAR ILAN UNIVERSITY (IL) | 2022-03-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12616760-B2 | Synthetic cyclic peptide mimetics | TPX2, IAPP, HAX1 | ECE1 2453/4885ERAP2 527/4885CCKAR 322/4885 |
| US-20240316225-A1 | SYNTHETIC CYCLIC PEPTIDE MIMETICS | IAPP, QPCTL, DNPEP | ECE1 2848/4885ERAP2 480/4885CCKAR 1851/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.